التفاصيل البيبلوغرافية
| العنوان: |
330 WEEK 48 RESULTS OF A PHASE 3 RANDOMIZED CONTROLLED TRIAL OF BICTEGRAVIR/EMTRICITABINE/TENOFOVIR ALAFENAMIDE (B/F/TAF) VS DOLUTEGRAVIR + EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (DTG+F/TDF) IN ART-NAIVE, HIV/HBV-COINFECTED ADULTS (ALLIANCE) |
| المؤلفون: |
Avihingsanon, Anchalee, Lu, Hongzhou, Leong, Chee Loon, Hung, Chien-Ching, Koenig, Ellen, Kiertiburanakul, Sasisopin, Lee, Man-Po, Supparatpinyo, Khuanchai, Rahman, Sophia, Brogan, Michelle D'Antoni, Wang, Hongyuan, Hindman, Jason, Martin, Hal, Mehta, Swarup S., Baeten, Jared, Zhang, Fujie |
| المصدر: |
In Gastroenterology May 2023 164(6) Supplement:S |
| قاعدة البيانات: |
ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder